IP Library Granted Patent US 11,284,819
Granted Patent B1
US 11,284,819 · App. 17/201,495 · Granted Mar 29, 2022

Analyte database established using analyte data from non-invasive analyte sensors

Inventors: Phillip Bosua (Seattle, WA); Ronald Erickson (Seattle, WA)
Assignee: KNOW LABS, INC.
A61B5/1455A61B5/0507A61B5/14532A61B5/14546A61B5/0002A61B5/681A61B5/7275A61B2503/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,284,819
App. No.
17/201,495
Granted
Mar 29, 2022
Kind
B1
Abstract

Establishing an analyte database using analyte data that has been obtained using non-invasive analyte sensors, and using the analyte database to analyze data obtained using a non-invasive analyte sensor. Once the analyte database is established, the analyte database can be updated with new analyte data, and the analyte database can be used to analyze the new analyte data to derive information from the new analyte data. For example, in the case of a human target, the new analyte data together with the analyte database can be used to predict an actual or possible abnormal medical pathology of the human target.

Claims (11)

1. An analytics system, comprising:

a receiving device that includes one or more processors and at least one storage device;

the at least one storage device comprising instructions, which when executed by the one or more processors, configure the receiving device to:

establish an analyte database that is based on analyte data that is obtained from interstitial fluid of similar targets by in vitro non-invasive analyte sensors that conduct a plurality of analyte sensing routines on the similar targets to obtain the analyte data from the interstitial fluid of the similar targets over a period of time, the analyte data containing information on at least one analyte in the interstitial fluid of the similar targets, and to receive the analyte data in a single transmission from each one of the in vitro non-invasive analyte sensors resulting from the plurality of the analyte sensing routines conducted by each one of the in vitro non-invasive analyte sensors, and each in vitro non-invasive analyte sensor includes:

an antenna array having at least three antennas disposed side-by-side to one another, each one of the at least three antennas comprising an elongated strip of conductive material with a longitudinal axis, each one of the at least three antennas has longitudinal ends, and the longitudinal ends of the at least three antennas differ in geometrical shape from one another, at least one of the at least three antennas is controlled to operate as a transmit antenna and at least one of the at least three antennas is controlled to operate as a receive antenna, and for each analyte sensing routine of the plurality of analyte sensing routines the transmit antenna transmits an electromagnetic transmit signal that includes at least one frequency in a range of from 10 kHz to 100 GHz into the interstitial fluid of the corresponding similar target and the receive antenna detects a response resulting from transmission of the electromagnetic transmit signal by the transmit antenna into the interstitial fluid of the corresponding similar target; a transmit circuit that is electrically connectable to the transmit antenna, the transmit circuit is configured to generate the electromagnetic transmit signal to be transmitted by the transmit antenna; and a receive circuit that is electrically connectable to the receive antenna, the receive circuit is configured to receive the response detected by the receive antenna.

2. The analytics system of claim 1 , further comprising the in vitro non-invasive analyte sensors, and the in vitro non-invasive analyte sensors are in direct and/or indirect communication with the receiving device.

3. The analytics system of claim 1 , further comprising intermediate devices that are in communication with the in vitro non-invasive analyte sensors and with the receiving device.

4. The analytics system of claim 1 , wherein the analyte data in the analyte database is raw unprocessed data obtained by the in vitro non-invasive analyte sensors, and wherein the instructions, when executed by the one or more processors, further configure the receiving device to:

analyze the raw unprocessed data using the one or more processors to generate analyzed data and store the analyzed data.

5. The analytics system of claim 1 , wherein the analyte data in the analyte database is raw unprocessed data obtained by the in vitro non-invasive analyte sensors, and wherein the instructions, when executed by the one or more processors, further configure the receiving device to:

analyze the raw unprocessed data to determine the presence of the at least one analyte in the interstitial fluid and/or a concentration of the at least one analyte in the interstitial fluid.

Assignments (5)
CHANGE OF NAME Recorded Aug 27, 2025
From: KNOW LABS, INC.
To: USBC, INC.
Reel/Frame 072590/0959 →
RELEASE OF SECURITY INTEREST Recorded Aug 26, 2025
From: LIND GLOBAL FUND II LP
To: KNOW LABS, INC.
Reel/Frame 072564/0180 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE NATURE OF THE CONVEYANCE FROM ASSIGNMENT TO SECURITY INTEREST PREVIOUSLY RECORDED ON REEL 66766 FRAME 901. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Mar 22, 2024
From: KNOW LABS, INC.
To: LIND GLOBAL FUND II LP
Reel/Frame 067126/0008 →
SECURITY INTEREST Recorded Mar 7, 2024
From: KNOW LABS, INC.
To: LIND GLOBAL FUND II LP
Reel/Frame 066766/0901 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2021
From: BOSUA, PHILLIP; ERICKSON, RONALD
To: KNOW LABS, INC.
Reel/Frame 055593/0486 →
Cited By (4)
US 1,099,332 US 12,193,810 US 12,318,182 US 12,318,203